Literature DB >> 229466

A convenient sequencing method for 5' protein-linked RNAs.

A Nomoto, N Imura.   

Abstract

A convenient nucleotide sequencing method for 5' end protein-linked RNAs was developed. Genome of LSc, 2ab poliovirus, which has a protein (VPg) covalently linked to the 5' terminus, was labelled with 125I Bolton and Hunter reagent after proteinase K treatment. No sign of labelling of nucleotide moiety in the genome with the reagent was detected. A labelled oligo peptide-linked ribonuclease T1 fragment was obtained from the 5' end of the genome. Analysis of the complex by two dimensional gel electrophoresis after partial alkali digestion or by the nucleotide sequencing method of Donis-Keller et al. (1) revealed that LSc, 2ab strain genome had an identical 5' end structure to that of Mahoney strain genome, that is, VPg-pUpUpApApApApCpApGp. Our results have shown that this labelling method is useful for analysis of 5' end sequence of RNAs linked to protein at the 5' termini.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229466      PMCID: PMC342299          DOI: 10.1093/nar/7.5.1233

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Identification of specific fragments containing the 5' end of poliovirus RNA after ribonuclease III digestion.

Authors:  T J Harris; J J Dunn; E Wimmer
Journal:  Nucleic Acids Res       Date:  1978-11       Impact factor: 16.971

2.  The genome-linked protein of picornaviruses. IV. Difference in the VPg's of encephalomyocarditis virus and poliovirus as evidence that the genome-linked proteins are virus-coded.

Authors:  F Golini; A Nomoto; E Wimmer
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

3.  The location of the polio genome protein in viral RNAs and its implication for RNA synthesis.

Authors:  A Nomoto; B Detjen; R Pozzatti; E Wimmer
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

4.  Untranslated vesicular stomatitis virus messenger RNA after poliovirus infection.

Authors:  E Ehrenfeld; H Lund
Journal:  Virology       Date:  1977-07-15       Impact factor: 3.616

5.  Protein covalently linked to foot-and-mouth disease virus RNA.

Authors:  D V Sangar; D J Rowlands; T J Harris; F Brown
Journal:  Nature       Date:  1977-08-18       Impact factor: 49.962

6.  Inhibition of translation by poliovirus: inactivation of a specific initiation factor.

Authors:  J K Rose; H Trachsel; K Leong; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

7.  The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg.

Authors:  A Nomoto; N Kitamura; F Golini; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Cowpea mosaic virus RNAs have neither m7GpppN ... nor mono-, di- or triphosphates at their 5' ends.

Authors:  J Klootwijk; I Klein; P Zabel; A van Kammen
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

9.  O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus.

Authors:  P G Rothberg; T J Harris; A Nomoto; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

10.  Sequence studies of poliovirus RNA. IV. Nucleotide sequence complexities of poliovirus type 1, type 2 and two type 1 defective interfering particles RNAs, and fingerprint of the poliovirus type 3 genome.

Authors:  Y F Lee; N Kitamura; A Nomoto; E Wimmer
Journal:  J Gen Virol       Date:  1979-08       Impact factor: 3.891

View more
  2 in total

1.  Stable hairpin structure within the 5'-terminal 85 nucleotides of poliovirus RNA.

Authors:  G R Larsen; B L Semler; E Wimmer
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

2.  The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription.

Authors:  C K Shieh; L H Soe; S Makino; M F Chang; S A Stohlman; M M Lai
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.